BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• Press Releases

  Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference - May 27, 2026

  May 27, 2026

   · 

  3 min read
• Press Releases

  FDA Approves Use of LINZESS® (linaclotide) in Pediatric Patients Two Years of Age and Older with Functional Constipation (FC)

  May 27, 2026

   · 

  12 min read
• 

  Immunology and inflammation

  Apogee investors riled by $1.3B royalty deal, as eczema drug matches Lilly’s Ebglyss

  Apogee’s pipeline in a product drug zumilokibart achieved significant disease clearance in a mid-stage atopic dermatitis trial, but investors were miffed by a royalty financing deal with Blackstone.

  May 27, 2026

   · 

  3 min read

   · 

  Annalee Armstrong
• Press Releases

  UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine

  May 27, 2026

   · 

  9 min read
• Press Releases

  Groundbreaking Headache Medicine Research on New Frontiers in Treatment, Biomarkers, and the Gut-Brain Axis to be Presented at the American Headache Society® 68th Annual Scientific Meeting

  May 27, 2026

   · 

  4 min read
• Press Releases

  Zealand Pharma to participate in the Jefferies Global Healthcare Conference 2026

  May 27, 2026

   · 

  1 min read
• Press Releases

  Lilly to participate in Goldman Sachs 47th Annual Global Healthcare Conference

  May 27, 2026

   · 

  2 min read
• Press Releases

  Stallergenes Greer Foundation Celebrates Excellence in Allergy Innovation With 2025 Awards

  May 27, 2026

   · 

  6 min read
• Press Releases

  Secretome Therapeutics Announces $30 Million Series A Financing From RA Capital Management to Advance STM-01 for Duchenne-Associated Cardiomyopathy

  May 27, 2026

   · 

  4 min read
• Press Releases

  PharmaEssentia Appoints Eric Vogel as U.S. Head of Commercialization Ahead of Potential Launch of BESREMi® in Essential Thrombocythemia

  May 27, 2026

   · 

  6 min read